BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puik JR, Meijer LL, Le Large TY, Prado MM, Frampton AE, Kazemier G, Giovannetti E. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma. Pharmacogenomics. 2017;18:1343-1358. [PMID: 28832247 DOI: 10.2217/pgs-2017-0010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Koustas E, Trifylli EM, Sarantis P, Papavassiliou AG, Karamouzis MV. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy. World J Gastrointest Oncol 2021; 13(10): 1229-1243 [PMID: 34721764 DOI: 10.4251/wjgo.v13.i10.1229] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rompianesi G, Di Martino M, Gordon-Weeks A, Montalti R, Troisi R. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World J Gastrointest Oncol 2021; 13(5): 332-350 [PMID: 34040697 DOI: 10.4251/wjgo.v13.i5.332] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Chen Z, Li Z, Soutto M, Wang W, Piazuelo MB, Zhu S, Guo Y, Maturana MJ, Corvalan AH, Chen X, Xu Z, El-Rifai WM. Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis. Gastroenterology 2019;156:1127-1139.e8. [PMID: 30502323 DOI: 10.1053/j.gastro.2018.11.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
4 Boyd LNC, Peters GJ, Kazemier G, Giovannetti E. NUC-1031 in biliary tract cancer: from bench to bedside and back? Cancer Chemother Pharmacol 2020;85:1011-4. [PMID: 32476108 DOI: 10.1007/s00280-020-04080-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Chen T, Lei S, Zeng Z, Pan S, Zhang J, Xue Y, Sun Y, Lan J, Xu S, Mao D, Guo B. MicroRNA‑137 suppresses the proliferation, migration and invasion of cholangiocarcinoma cells by targeting WNT2B. Int J Mol Med 2020;45:886-96. [PMID: 31985024 DOI: 10.3892/ijmm.2020.4474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang L, Bluth MH, Bhalla A. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract: 2018 Update. Clin Lab Med 2018;38:367-84. [PMID: 29776636 DOI: 10.1016/j.cll.2018.03.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Almenar-Pérez E, Sánchez-Fito T, Ovejero T, Nathanson L, Oltra E. Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments. Pharmaceutics 2019;11:E126. [PMID: 30889846 DOI: 10.3390/pharmaceutics11030126] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
8 Guo L, Dou Y, Yang Y, Zhang S, Kang Y, Shen L, Tang L, Zhang Y, Li C, Wang J, Liang T, Li X. Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma. Comput Struct Biotechnol J 2021;19:5722-34. [PMID: 34745457 DOI: 10.1016/j.csbj.2021.10.014] [Reference Citation Analysis]
9 Zu B, Liu L, Wang J, Li M, Yang J. MiR-140-3p inhibits the cell viability and promotes apoptosis of synovial fibroblasts in rheumatoid arthritis through targeting sirtuin 3. J Orthop Surg Res 2021;16:105. [PMID: 33530998 DOI: 10.1186/s13018-021-02236-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Huang C, Qin X, Zhao N, Jin H, Zhang S, Yang H. MicroRNA-100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition. Oncol Lett 2020;20:1336-44. [PMID: 32724376 DOI: 10.3892/ol.2020.11686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hu J, Wang YN, Song DJ, Tan JP, Cao Y, Fan J, Wang Z, Zhou J. A High-Accuracy Model Based on Plasma miRNAs Diagnoses Intrahepatic Cholangiocarcinoma: A Single Center with 1001 Samples. Diagnostics (Basel) 2021;11:610. [PMID: 33805513 DOI: 10.3390/diagnostics11040610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liu C, Yu Z, Huang S, Zhao Q, Sun Z, Fletcher C, Jiang Y, Zhang D. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC. EBioMedicine 2019;50:135-43. [PMID: 31780396 DOI: 10.1016/j.ebiom.2019.11.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
13 Loeffler MA, Hu J, Kirchner M, Wei X, Xiao Y, Albrecht T, De La Torre C, Sticht C, Banales JM, Vogel MN, Pathil-Warth A, Mehrabi A, Hoffmann K, Rupp C, Köhler B, Springfeld C, Schirmacher P, Ji J, Roessler S, Goeppert B. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis. J Pathol 2020;252:239-51. [PMID: 32710569 DOI: 10.1002/path.5514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Chen L, Huang X, Chen X. miR-365 Suppresses Cholangiocarcinoma Cell Proliferation and Induces Apoptosis by Targeting E2F2. Oncol Res 2018;26:1375-82. [PMID: 29471889 DOI: 10.3727/096504018X15188352857437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
15 Huang WK, Yeh CN. The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma. Biomolecules. 2020;10. [PMID: 33007962 DOI: 10.3390/biom10101396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Cui S, Lou S, Guo W, Jian S, Wu Y, Liu X, Lan X, Jia X. Prediction of MiR-21-5p in Promoting the Development of Lung Adenocarcinoma via PDZD2 Regulation. Med Sci Monit 2020;26:e923366. [PMID: 32535612 DOI: 10.12659/MSM.923366] [Reference Citation Analysis]
17 Zhang J, Li D, Zhang R, Gao P, Peng R, Li J. The miR-21 potential of serving as a biomarker for liver diseases in clinical practice. Biochem Soc Trans 2020;48:2295-305. [PMID: 33119045 DOI: 10.1042/BST20200653] [Reference Citation Analysis]
18 Meijer LL, Puik JR, Le Large TYS, Heger M, Dijk F, Funel N, Wurdinger T, Garajová I, van Grieken NCT, van de Wiel MA, Giovannetti E, Kazemier G. Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors. Cancers (Basel) 2019;11:E1181. [PMID: 31443224 DOI: 10.3390/cancers11081181] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
19 Zhang D, Li H, Xie J, Jiang D, Cao L, Yang X, Xue P, Jiang X. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma. Int J Oncol 2018;52:1777-86. [PMID: 29620172 DOI: 10.3892/ijo.2018.4362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
20 Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, Tao Y, He Z, Chen C, Jiang Y. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5:145. [PMID: 32759948 DOI: 10.1038/s41392-020-00261-0] [Cited by in Crossref: 77] [Cited by in F6Publishing: 88] [Article Influence: 38.5] [Reference Citation Analysis]
21 Zhou M, Dong Z, Hu S, Xiao M. LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells. Eur Arch Otorhinolaryngol 2021;278:3363-74. [PMID: 33479848 DOI: 10.1007/s00405-021-06607-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Weng S, Janssen HLA, Zhang N, Tang W, Bai E, Yang B, Dong L. CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma. Dig Dis Sci 2020;65:1053-63. [PMID: 31562609 DOI: 10.1007/s10620-019-05843-9] [Reference Citation Analysis]
23 Lv P, Luo YF, Zhou WY, Liu B, Zhou Z, Shi YZ, Huang R, Peng C, He ZL, Wang J, Zhang HH, Nie SD. miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1. Kaohsiung J Med Sci. 2020;36:429-440. [PMID: 32125086 DOI: 10.1002/kjm2.12191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Shotton R, Lamarca A, Valle J, McNamara MG. Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review. World J Gastrointest Oncol 2021; 13(9): 1073-1085 [PMID: 34616513 DOI: 10.4251/wjgo.v13.i9.1073] [Reference Citation Analysis]
25 Yin X, Chai Z, Sun X, Chen J, Wu X, Yang L, Zhou X, Liu F. Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via MTSS1. Exp Ther Med 2020;19:2757-65. [PMID: 32256758 DOI: 10.3892/etm.2020.8502] [Reference Citation Analysis]
26 Cheng M, Yang Y, Xin H, Li M, Zong T, He X, Yu T, Xin H. Non-coding RNAs in aortic dissection: From biomarkers to therapeutic targets. J Cell Mol Med 2020;24:11622-37. [PMID: 32885591 DOI: 10.1111/jcmm.15802] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
27 Fu Y, Yang X, Chen H, Lu Y. Diagnostic value of miR-145 and its regulatory role in macrophage immune response in tuberculosis. Genet Mol Biol 2020;43:e20190238. [PMID: 32614357 DOI: 10.1590/1678-4685-GMB-2019-0238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]